Scanfil (SCANFL) Malmö Factory Tour Presentation summary

Growth trajectory and financial performance

• Achieved rapid internationalization and significant growth, with turnover rising from €5M to over €900M between 2012 and 2023, maintaining a CAGR of 15.4% in revenue and 14.2% in margin improvement over the past decade.

• 2024 presents a more challenging environment, but long-term targets remain: 10% annual growth, EBIT margin of 7–8%, and net debt/EBITDA below 1.5x.

• Return on equity has remained strong, with a 2023 equity ratio of 54.3% and gearing at 19.5%.

• Growth capacity is projected to reach €1.15B by 2028, with both organic and inorganic expansion.

Strategic positioning and operations

• Focuses on low to mid-volume, high-mix manufacturing for industrial, medtech, and cleantech clients, with system integration and box build capabilities.

• Global footprint includes sites in Sweden, Finland, Estonia, Poland, Germany, USA, and China, with a diversified customer base across industrial, energy, and medtech sectors.

• Customer diversification has increased, reducing reliance on the largest clients and expanding across sectors.

Regional structure and management

• New management structure empowers regions (Americas, APAC, Northern and Central Europe) with clear targets for turnover, margin, and M&A initiatives.

• Regions are responsible for their own growth, profitability, and local M&A, increasing transparency and autonomy.